Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,285.50
-9.00 (-0.39%)
Jun 19, 2026, 1:15 PM JST
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 518.48 billion as of June 18, 2026. Its market cap has increased by 12.75% in one year.
Market Cap
518.48B
Enterprise Value
510.25B
Revenue
343.73B
Ranking
n/a
PE Ratio
15.79
Stock Price
2,285.50
Market Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 518.48B, an increase of 698.31%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 518.48B | -12.69% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.62T |
| Shiseido Company | 1.04T |
| Lion Corporation | 456.08B |
| Paltac | 402.62B |
| Kobayashi Pharmaceutical | 399.57B |
| KOSE Holdings | 292.19B |
| MTG Co., Ltd. | 287.54B |
| Pola Orbis Holdings | 277.27B |